Prognostic factors of work disability in sick-listed cancer survivors

被引:21
作者
van Muijen, Peter [1 ,2 ,3 ]
Duijts, Saskia F. A. [1 ,3 ]
van der Beek, Allard J. [1 ,3 ]
Anema, Johannes R. [1 ,3 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Publ & Occupat Hlth, NL-1007 MB Amsterdam, Netherlands
[2] Dutch Social Secur Agcy, Amsterdam, Netherlands
[3] Res Ctr Insurance Med, Amsterdam, Netherlands
关键词
Work disability; Prognostic factors; Cancer survivors; Vocational rehabilitation; Functional abilities; BREAST-CANCER; PROSPECTIVE COHORT; JOB LOSS; RETURN; EMPLOYMENT; DIAGNOSIS; IMPACT; DETERMINANTS; REEMPLOYMENT; EMPLOYEES;
D O I
10.1007/s11764-013-0297-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sick-listed cancer survivors may face lasting side-effects, even after a successful completion of treatment. As a consequence, they are at risk of work disability, which may lead to job loss. Knowledge of prognostic factors of work disability may support cancer survivors in their trajectory of vocational rehabilitation. The purpose of this study was to identify prognostic factors of work disability in sick-listed cancer survivors. From the first day of sick leave, a cohort of 131 cancer survivors was followed for 24 months. Included participants were aged between 20 and 63 years. Data were collected, using questionnaires, at 10 months after reporting sick. The level of work disability, i.e., entitlement for disability compensation, was assessed by an insurance physician and a labour expert at 24 months. Univariate and multiple logistic regression analyses were performed. In the univariate analysis, 14 variables were found to be associated with the level of work disability at 24 months. These factors were related to socio-demographics, health characteristics, work-related characteristics, and return to work (RTW) expectations. Multiple logistic regression showed that at 10-month sick leave, perception of health care providers on cancer survivors' work ability and experienced influence on RTW, both reported by workers, were significantly associated with the level of work disability at 24 months. It seems in the interest of cancer survivors to take an active role in planning their RTW trajectory and to discuss RTW with their health care providers. The potential role healthcare providers may play in counselling cancer survivors on RTW must not be underestimated. Cancer survivors may benefit in having control on their RTW trajectory.
引用
收藏
页码:582 / 591
页数:10
相关论文
共 53 条
  • [1] Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them
    Ahn, Eunmi
    Cho, Juhee
    Shin, Dong Wook
    Park, Byeong Woo
    Ahn, Sei Hyun
    Noh, Dong-Young
    Nam, Seok Jin
    Lee, Eun Sook
    Yun, Young Ho
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (03) : 609 - 616
  • [2] Cancer survivorship and employment: epidemiology
    Amir, Z.
    Brocky, J.
    [J]. OCCUPATIONAL MEDICINE-OXFORD, 2009, 59 (06): : 373 - 377
  • [3] [Anonymous], MINERVA PSICHIAT
  • [4] [Anonymous], 2005, GAZETTE, P572
  • [5] [Anonymous], 2012, SPSS 15 0 1
  • [6] Return to work after early-stage breast cancer: A cohort study into the effects of treatment and cancer-related symptoms
    Balak, Fulya
    Roelen, Corne A. M.
    Koopmans, Petra C.
    ten Berge, Elike E.
    Groothoff, Johan W.
    [J]. JOURNAL OF OCCUPATIONAL REHABILITATION, 2008, 18 (03) : 267 - 272
  • [7] Work and retirement after cancer diagnosis
    Bednarek, HL
    Bradley, CJ
    [J]. RESEARCH IN NURSING & HEALTH, 2005, 28 (02) : 126 - 135
  • [8] BERGMAN B, 1987, EUR J RESPIR DIS, V70, P49
  • [9] Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal
    Borget, I.
    Corone, C.
    Nocaudie, M.
    Allyn, M.
    Iacobelli, S.
    Schlumberger, M.
    De Pouvourville, G.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (05) : 531 - 538
  • [10] Correlates of return to work for breast cancer survivors
    Bouknight, RR
    Bradley, CJ
    Luo, ZH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) : 345 - 353